The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma
Conditions: Clinical IVb Stage Oral Squamous Cell Carcinomas Patients Interventions: Drug: Adebrelimab Sponsors: Hospital of Stomatology, Wuhan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | COVID-19 | Hospitals | Neoadjuvant Therapy | Oral Cancer | Research | Skin Cancer | Squamous Cell Carcinoma